Excelsior Medical Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Excelsior Medical.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 17.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 31 May 2024 |
Recent future growth updates
Recent updates
There's Been No Shortage Of Growth Recently For Excelsior Medical's (TPE:4104) Returns On Capital
Apr 22A Look At The Intrinsic Value Of Excelsior Medical Co., Ltd. (TPE:4104)
Apr 07What To Know Before Buying Excelsior Medical Co., Ltd. (TPE:4104) For Its Dividend
Feb 25Excelsior Medical (TPE:4104) Could Easily Take On More Debt
Feb 07Returns On Capital - An Important Metric For Excelsior Medical (TPE:4104)
Jan 22Excelsior Medical (TPE:4104) Has Compensated Shareholders With A Respectable 46% Return On Their Investment
Jan 07Excelsior Medical Co., Ltd. (TPE:4104) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 23Does Excelsior Medical's (TPE:4104) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 08Does Excelsior Medical Co., Ltd. (TPE:4104) Have A Place In Your Dividend Portfolio?
Nov 23In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Excelsior Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 8,742 | N/A | 694 | 694 | 1 |
3/31/2024 | 8,269 | 730 | 823 | 969 | N/A |
12/31/2023 | 8,233 | 747 | -36 | 107 | N/A |
9/30/2023 | 8,012 | 716 | -53 | 105 | N/A |
6/30/2023 | 7,833 | 734 | 13 | 164 | N/A |
3/31/2023 | 7,485 | 701 | 183 | 331 | N/A |
12/31/2022 | 7,187 | 667 | 465 | 637 | N/A |
9/30/2022 | 7,011 | 682 | 775 | 893 | N/A |
6/30/2022 | 6,746 | 648 | 573 | 669 | N/A |
3/31/2022 | 6,652 | 644 | 683 | 781 | N/A |
12/31/2021 | 6,573 | 607 | 776 | 945 | N/A |
9/30/2021 | 6,456 | 577 | 916 | 1,087 | N/A |
6/30/2021 | 6,566 | 555 | 869 | 1,028 | N/A |
3/31/2021 | 6,571 | 564 | 1,125 | 1,261 | N/A |
12/31/2020 | 6,675 | 572 | 834 | 869 | N/A |
9/30/2020 | 6,709 | 545 | 1,208 | 1,263 | N/A |
6/30/2020 | 6,632 | 543 | 1,142 | 1,199 | N/A |
3/31/2020 | 6,593 | 523 | 885 | 938 | N/A |
12/31/2019 | 6,457 | 515 | 1,142 | 1,194 | N/A |
9/30/2019 | 6,387 | 511 | 1,035 | 1,072 | N/A |
6/30/2019 | 6,371 | 477 | 804 | 848 | N/A |
3/31/2019 | 6,390 | 477 | 192 | 235 | N/A |
12/31/2018 | 6,345 | 452 | 156 | 192 | N/A |
9/30/2018 | 6,285 | 422 | -428 | -392 | N/A |
6/30/2018 | 6,209 | 403 | 12 | 42 | N/A |
3/31/2018 | 6,161 | 376 | 385 | 416 | N/A |
12/31/2017 | 6,095 | 399 | N/A | -487 | N/A |
9/30/2017 | 6,126 | 397 | N/A | -268 | N/A |
6/30/2017 | 6,156 | 401 | N/A | 48 | N/A |
3/31/2017 | 6,203 | 387 | N/A | -222 | N/A |
12/31/2016 | 6,206 | 390 | N/A | 450 | N/A |
9/30/2016 | 6,171 | 412 | N/A | 798 | N/A |
6/30/2016 | 6,215 | 407 | N/A | 173 | N/A |
3/31/2016 | 6,221 | 422 | N/A | 1,006 | N/A |
12/31/2015 | 6,203 | 378 | N/A | 740 | N/A |
9/30/2015 | 6,123 | 329 | N/A | 610 | N/A |
6/30/2015 | 5,995 | 319 | N/A | 535 | N/A |
3/31/2015 | 5,898 | 292 | N/A | 368 | N/A |
12/31/2014 | 5,807 | 286 | N/A | 737 | N/A |
9/30/2014 | 5,864 | 272 | N/A | 566 | N/A |
6/30/2014 | 5,846 | 279 | N/A | 883 | N/A |
3/31/2014 | 5,813 | 326 | N/A | 71 | N/A |
12/31/2013 | 5,741 | 300 | N/A | 357 | N/A |
9/30/2013 | 5,620 | 309 | N/A | 73 | N/A |
6/30/2013 | 5,609 | 319 | N/A | 357 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4104's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 4104's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 4104's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 4104's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 4104's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4104's Return on Equity is forecast to be high in 3 years time